Levin Capital Strategies, L.P. Bio Rad Laboratories, Inc. Transaction History

Levin Capital Strategies, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$351.71 - $456.01 $297,898 - $386,240	847 New	847 $356,000
Q2 2022 Aug 15, 2022	SELL	$463.67 - $597.16 $231,835 - $298,580	-500 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$524.57 - $735.42 $262,285 - $367,710	500 New	500 $282,000
Q1 2019 May 13, 2019	SELL	$224.3 - $317.41 $128 Million - $181 Million	-569,205 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$220.1 - $309.0 $124 Million - $173 Million	561,328 Added 7126.16%	569,205 $132 Million
Q3 2018 Oct 29, 2018	BUY	$289.28 - $326.15 $987,601 - $1.11 Million	3,414 Added 76.5%	7,877 $2.47 Million
Q2 2018 Aug 07, 2018	SELL	$244.1 - $303.88 $2.24 Million - $2.79 Million	-9,179 Reduced 67.28%	4,463 $1.29 Million
Q1 2018 May 18, 2018	BUY	$233.97 - $274.11 $3.19 Million - $3.74 Million	13,642 New	13,642 $3.41 Million

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

Stay updated on Levin Capital Strategies, L.P. with notifications on news.